Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: A comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 400-404

  Rodríguez Tudela, Juan L ^a   Martín Díez, Francisco ^a   Cuenca Estrella, Manuel ^a   Rodero, Laura ^b   Carpintero, Yolanda ^a   Gorgojo, Begoña ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; OXYGEN;

ANTIBIOTIC SENSITIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; FUNGUS GROWTH; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; CELL DIVISION; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIA; GLUCOSE; HUMANS; MICROBIAL SENSITIVITY TESTS; SACCHAROMYCES CEREVISIAE; SPECIMEN HANDLING;

EID: 0343986460     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.400-404.2000     Document Type: Article

References (10)

1. Ghannoum, M. A., A. S. Ibrahim, Y. Fu, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1992. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin. Microbiol. 30:2881-2886.
2. Larsen, R. A., S. A. Bozzette, B. E. Jones, D. Haghighat, M. A. Leal, D. Forthal, M. Bauer, J. G. Tilles, J. A. McCutchan, and J. M. Leedom. 1994. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 19:741-745.
3. Lozano-Chiu, M., V. L. Paetznick, M. A. Ghannoum, and J. H. Rex. 1998. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J. Clin. Microbiol. 36:2817-2822.
4. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. Odds, F. C., T. De Backer, G. Dams, L. Vranckx, and F. Woestenborghs. 1995. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J. Clin. Microbiol. 33:995-997.
6. Odds, F. C., L. Vranckx, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob. Agents Chemother. 39:2051-2060.
7. Powderly, W. G., E. J. Keath, M. Sokol-Anderson, D. Kitz, and G. Kobayashi. 1992. Amphotericin-B resistant Cryptococcus neoformans in a patient with AIDS. Infect. Dis. Clin. Pract. 1:314-316.
8. Rodríguez-Tudela, J. L., J. Berenguer, J. V. Martínez-Suárez, and R. Sanchez. 1996. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosinc, and fluconazole against Candida albicans. Antimicrob. Agents Chemother. 40:1998-2003.
9. Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1994. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
10. Rodriguez Tudela, J. L., and J. V. Martinez Suarez. 1995. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J. Antimicrob. Chemother. 35:739-749.